Pharm Exec published on May 2010 the ranking of the 50 largest pharmaceutical world groups by global sales of prescription drug products. Over the Counter products were not considered on this study.
2009 mergers cause the disappearance of some laboratories from the previous list. Wyeth, previously number 10 on 2009, is now part of Pfizer, number 1; Schering-Plough, number 15 on 2009, merged with Merck, producing a company which will probably rank to number 4 on 2011; Genetech (19) was acquired by Roche; Warner-Chilcott which was not present in this list will climb to the middle of the list on 2011.
| 1. Pfizer 2. Sanofi -Aventis 3. Novartis 4. GlaxoSmithKline 5. Roche 6. AstraZeneca 7. Merck 8. Johnson & Johnson 9. Eli Lilly 10. Bristol-Myers Squibb 11. Abbott 12. Bayer 13. Boehringer Ingelheim 14. Amgen 15. Takeda 16. Teva 17. Novo Nordisk 18. Astellas 19. Daiichi Sankyo 20. Otsuka 21. Eisai 22. Merck KGaA 23. Gilead Sciences 24. Baxter International 25. Mylan |
26. Servier 27. Chugai 28. Genzyme 29. Mitsubishi Tanabe 30. UCB 31. CSL 32. Allergan 33. Forest 34. Menarini 35. Nycomed 36. Biogen Idec 37. Shire 38. Alcon 39. Apotex 40. Lundbeck 41. Celgene 42. Ratiopharm 43. Cephalon 44. Dainippon Sumitomo 45. Hospira 46. Watson 47. Actavis 48. Shionogi 49. Kyowa Hakko Kirin 50. Meda |
